搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
Money Talks News on MSN
6 小时
Don't Ignore These Early Signs of a Progressive Liver Condition
A progressive liver condition affects thousands of Americans, but early symptoms are often dismissed as everyday ailments.
1 天
Why the HMPV virus is the least of your worries: Watch out for the winter flu
Doctors assumed he had the seasonal flu and thought he would get better with proper nutrition, hydration and rest. But his ...
2 天
Woman from Myanmar undergoes liver transplant at hospital in Chennai
A 66-year-old woman from Myanmar underwent a liver transplant surgery at a private hospital in the city.
来自MSN
2 天
What To Know About Biliary Colic (Gallbladder Attack) Treatment
Medically reviewed by Jay N. Yepuri, MD Biliary colic is abdominal pain that develops due to a blockage in the bile ducts, ...
3 天
Two clinical trials show that immunotherapy with current treatment is effective.
Immunotherapy, a form of treatment that uses the body’s immune system to find and fight cancer cells, can delay the ...
Healio
4 天
Cour Pharmaceuticals snags orphan drug designation for CNP-104 for the treatment of PBC
The FDA has granted Cour Pharmaceuticals orphan drug designation for CNP-104, a biodegradable nanoparticle in development for ...
4 天
Compass Therapeutics Provides Corporate Update and Announces Advancement of a New Drug ...
Top-line Phase 2/3 data readout for CTX-009, now named tovecimig (a DLL4 x VEGF-A bispecific), in patients with biliary tract cancer (BTC) is on ...
manilatimes
4 天
Gain Therapeutics Announces Formation of Clinical Advisory Board to Support Continued ...
Gain Therapeutics, Inc. (Nasdaq: GANX) ("Gain”, or the "Company”), a clinical-stage biotechnology company leading the ...
4 天
COUR Pharmaceuticals Secures FDA Orphan Drug Designation for CNP-104 in Primary Biliary ...
COUR Pharmaceuticals, a clinical-stage biotechnology company developing first-in-class, disease-modifying therapies designed ...
腾讯网
5 天
年度盘点丨陆荫英教授:2024年胆道恶性肿瘤研究进展
编者按:岁月匆匆,一年的时光转瞬即逝,我们站在时间的交汇点上,回首往昔。在过去的一年里,胆道恶性肿瘤(BTC)领域的研究取得了诸多可喜进展,本刊特邀请解放军总医院第五医学中心陆荫英教授对其进行盘点总结。在2024年BTC领域的多项关键临床研究中,TO ...
6 天
Old ailment, known pathogen: A warning against HMPV panic
HMPV is a common respiratory virus with low alarm; many are exposed by age 5. Current Indian cases are mild, with no unusual ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈